The behaviour of the antifertilizing synthetic steroid RU 38486 towards human uterine progestin receptor was investigated. RU 38486 competed in the same order of magnitude äs progesterone for the [ 3 H]R 5020 binding site of progestin receptor, whereas R 5020 was unable to compete against [ 3 H]RU 38486. This apparent contradiction could be explained by means of HPLC-chroniatography. HPLC-chromatography with an anion exchange column (MonoQ, Pharmacia, Uppsala, Sweden) showed that [ 3 H]RU 38486 forms at least two stable complexes with uterine cytosol, on one hand with serum albumin, which presents almost 90% of bound radioactivity, and on the other hand with the two native progestin receptor forms, corresponding to 4 S and 8 S receptor forms in sucrose density gradient analysis.
Introduction
progesterone in vivo, a property that is manifested "~~ ~^ , , ^ . ,~ intheinterruptionofthelutealphaseofthemenstrual RU 38486 (structure see scheine 1) is the first cycle of ^y pregnancy in women . synthetic steroid possessmg a greater afnnity for the progestin receptor in different animal target tissues There are some indications that the potent antagonist than progesterone, but without exhibiting any agonist effect of RÜ 38486 is related to the essential bioprogestin activity (1) (2) (3) . Moreover, at large doses chemical Steps following progestin receptor this steroid is capable of antagonizing the effects of occupancy which leäd to the biological response i. e.
H-Labelled RU 38486 binding sites in human uterine cytosol Schemel. Chemical structure and chemical nomenclature of I RU 38486: 17ß-hydroxy-21-methyl-l lß(4-dimethylaminopheriyl)-19-nor-4,9 pregnadiene-20-yne-3^one II Org2058: 16a-ethyM9-nor-21-hydroxy-4-pregnene-3,20-dione III R 5020, promegestone: 17a, 21-dimethyl-19-nor-4,9-pregnadiene-3,20?dione activation of the cytosolic progestin receptor and the nuclear translocation. Like other antihormones (e. g. some antiglucocorticoids which have been described äs effective in vitro) (4-8) a possible mechanism of the antifertility effect of RU 38486 could be in forming a less stable complex with the cytosolic receptor, which is unable to translocate properly into the nucleus and trigger a progesterone response.
In view of the hypothesis described above, the following investigation was undertaken. The aim was to present a comparison of biochemical and physical properties of the complexes which the human uterine progestin receptor forms with the well-established progestins progesterone, R 5020 and Org2058 on the one hand and with RU 38486 (structure and nomenclature see scheme 1) on the other hand.
Moreover, since binding to polyanions has been taken äs a test for activation, the binding of the "saltactivated" RU 38486-and R5020-progestin receptor complexes to DNA-cellulose was compared. H]dexamethasone (specific activity 3034 GBq/mmol) and unlabeled Org2058 were purchased from the Radiochemical Centre (Amersham UK). Radioinert and tritiated RU 38486 (specific activity 1850 GBq/mmol) were a generous gift from RoussellUclaf Laboratories. All these steroids were kept in benzeneethanol (85/15, vol/vol) at 4 °C and checked regularly for purity by thin-layer chromatography.
Materials and Methods
Nonradioactive steroids for competition experiments were obtained from Sigma Chemical Company (St. Louis, USA) and not further purified. All solvents used were obtained from Merck (Darmstadt, FRG) and were Uvasol grade.
Preparation of tissue samples
Human uteri were obtained after hysterectomy on the following indications: myomata uteri and prolapsus uteri. Immediately after hysterectomy an adequate sample was sent for histölogical examination and the fest was washed in ice-cold saline to remove mucous and blood. Then the tissue speeimens were snap frözen in liquid nitrogen and stored at -80 °C until use.
For cytosol preparation, uterine tissues were minced and homogenized with an Ultra Tufrax at 0-4°C in ice-cold buffef consisting of 10 mmol/1 KH 2 PO 4 , 10 rnmol/1 K 2 HPO 4 , 1.5 mmol/1 EDTA, 3 mmol/1 NaN 3 , glycerol, volume fraction 0.1, pH 7.5. The homogenates were then centrifuged at 105000g at 4°C for 30 min. The supernatant was taken äs cytosol. Rat liver and kidney cytosols from adrenalectomized feinale Wistar rats (150-200g) were prepared in the same way äs the uterine cytosol. For HPLC (high performance liquid chromatography) cytosol was prepared in ice-cold Tris/HCl-EDTA-buffer (20 ]RU 38486 together with a 200-ibld molar excess of unlabeled RÜ 38486 or R 5020 ünder identical incubation conditions. All incubations were carried out in triplicate. At the time intervals indicated, the unböund steroid was removed by the additipn of 0.5ml aliquots dextran-coated charcoal suspen^· sion (5 g/l Norit A, 0.5 g/l Dextran T400 in 10 mmoi/1 K 2 HPO 4 , 10 mmol/1 KH 2 PO 4 , 1.5 mmol/1 EDTA, 3 mmol/1 NaN 3 and glycerol, volume fraction 0.1, pH 7.5). The tubes were incubated for 10 min at 4°C, followed by 10 min centrifugation at 1500g. Supernatant (0.5ml) was placed in scintillation viäls, followed by the addition of l Oral scintillation cocktail, then counted for radioactivity.
Time-dependent dissociation of the 4, 7h. This was followed by centrifugation and determmätion of protein-bound radioactivity äs described above.
Titration of specific steroid binding sites
The binding constants and receptor capacities were determined by multipoint titration using Scatchard analysis of the data (9) . The crude cytosol in phosphate/EDTA/NaN 3 /glycerol-buffer, pH 7.5 was incubated for 16h at 0-4°C with various concentrations of 3 H-labeled R5020 and RU 38486 over the r nge which should saturate the receptors (0.5-8 nmol/1). Additional cytosols were incubated with tritiated ligands in the presence of a 200-fold excess of Uhlabeled ligands, in order to determine the extent of nonspecific binding. Unbound ligand was removed from receptor-associated ligand by using dextran-coated charcoal.
Specificity of the receptor binding
The tubes for competition assays were prepared s follows: to each tube 50 μΐ of 3 H-labeled steroids (in phosphate/EDTA/ NaN 3 /glycerol-buffer, pH 7.5) were pipetted to give a final concentration of 32 nmol/1. Then aliquots of 50 μΐ, containing the various competitors (in phosphate/EDTA/NaN 3 /glycerolbuffer, pH 7.5) at six different concentrations (10~1 0 -10~5 mol/1) were added. Finally, to each tube 100 μΐ of cytosol were added, and after gentle shaking the tubes were incubated overnight at 4°C. The reactions were terminated by the addition of 0.5 ml dextran-coated charcoal. After 10 min incubation under gentle shaking the tubes were centrifuged for 10 min at 1500g. AJiquots (0.5ml) of the supernatant were transferred to scintillation vials, and after addition of 10ml scintillatibn cocktail they were counted for radioactivity. All determinations were carried out in triplicate. The min"
1 -values were expressed s % binding, taking the values for the tubes containing only 3 H-ligands s 100%.
Serum binding
A pool of human pregnancy serum was stripped of endogeneous steroids with dextran-coated charcoal. Aliquots of this serum pool in a dilution of 1:10 with phosphate/EDTA/NaN 3 / glycerol-buffer, pH 7.5 were incubated in triplicate for 60 min at room temperature with 8 nmol/1 [ In another prepafation 10 mmpl/1 spdium m lybdate was added to the homogenization buffer, and cytosol was incubated s described above. Aliquots (1ml) of each incubation mixture were heat activated for 30 min at 37 °C. Aliquots (500 ,μΐ) were filtered through a Millex GV 0.22 μηι filter unit (Millipore, Neu-Isenburg, F.R.G.), then injeeted onto the col mn.
Chtomatography was carried out on the Pharmacia HPLC System (FPLC, Pharmacia, Uppsala, Sweden) fitted with a prepacked Mono Q col mn (high efficiency anion e*changer based on monodisperse 10 μηι spheres, Pharmacia, Uppsala, Sweden). The col mn was equilibrated in Tris/HCl-EDTA-buffer at 20 °C and eluted at a flow rate pf 2 ml/min with a NaCl gradient to l mol/1. Protein was monitored at 280 nm. Fractions (500 μΐ) were collected and radioactivity was measured by liquid scintillation counting (Ready-Solv HP, Beckman, Munich, F.R.G.).
Sucrose density gradient analysis
In 0.5 ml aliquots of all incubation mixtures, described in the paragraph on HPLC, nbound steroid was removed with dextran-coated charcoal. Aliquots of 0.2 ml were then layered on top of 5 -30% linear sucrose gradients. The gradients were centrifuged for 2.5h at 4°C at 404000g in a vertical rotor (Beckman VTi65). The gradients were collected from the bottom in 40 fractions. The gradients were standardized with FITC-labeled bovine serum albumin (M r = 67000) and FITClabeled IgG (M T = 150000) (Behring Werke, Marburg, F.R.G.).
Assay of receptor binding to DNA-cellulose
Cytosol fractions were incubated with 32 nmol/1 3 H-labelled steroid alone or with a 200-fold molar excess of the respective unlabeled steroid for 16h. Activation of steroid receptor complex was accomplished by adding a solution of 2 mol/1 NaCl in phosphate/EDTA/NaN 3 /glycerol-buffer, pH 7.5 to a final concentration of 0.4 mol/I NaCl. This mixture was kept for 40 min at 4°C. Now 100 μΐ activated cytosols were diluted with 700 μΐ buffer and were incubated for 20 min at 4°C with a DNA-cellulose pellet (Sigma Munich, F.R.G.) from 200 μΐ of a 25% slurry of DNA-cellulose. After centrifugation for l min at 2000g the samples were washed three times in cold buffer and the final pellet was taken for determination of radioactivity. All determinations were carried out in triplicate.
Protein determination
The protein concentrations were determined with the BioRad protein assay kit (BioRad, Richmond, USA) using bovine serum albumin s a Standard. The results in figure 9 and 10 illustrate HPLC of differently labeled uterine progestin receptors on a Mono Q anion exchange column. Free steroid was eluted with the washing buffer. Independent of the [ 3 H]labelled steroid used, the specifically labeled proteins eluted äs peak A and Ö (approximately 0.075 and 0.13 mol/1 NaCl). Peak B was not detectable after heat activation (20 min, 37 °C) and is probably identical with the 8 S bindirjg protein in sucrose density gradient analysis (data will be pubfrshed in detäil elsewhere). The nonspecifically labeled protein (peak C) eluting at 0.22 mol/1 NaCl was found in all preparations and showed identical behaviour to serum albumin (LC-partigen albumin immunodiffusion plates, Behring-Werke, Marburg, F.R.G., fig.ll) Fraction no. It seems obvious that the dimethylaminophenyl side group on carbon 11 is responsible for the high capacity binding to serum albumin, bec use a free electron pair can interact with free carboxy groups of aspartic and glutamic acids of albumin, which act s proton donors. The question of whether RU 38486 exerts its antihormonal action via the well established receptor interactions or via modified actions cannot be answered at the moment. Different modes of action, such s interaction with carboxyl groups within or apart the steroid binding side, changing the protein conformation or sealing the binding site, could prohibit either binding of naturally occurring steroids or translation of the steroid receptor complexes into the nucleus.
Results

Time studies of [
The reduced binding of salt-activated RU 38486-receptor complexes to DNA-cellulose is not nessarily due to reduced activation but might also reflect the distribution of binding equilibria between albumin and receptor, thus reducing the availability of added RU 38486 for the progestin receptor. On the other band, it was demonstrated for a broad spectrum of antiglucocorticoids that their antihormonal action is due to the formation of labile cytoplasmic steroid receptor complexes with a decreased or absent capacity for translocation (5, (14) (15) (16) (17) (18) . This phenomenon is not general but tissue-specific. Carboxamide derivatives of dexamethasone, for example, are antiglucocorticoids in hepatoma cells (19) , but are potent agonists in human peripheral lymphocytes (20) .
RU 38486 not only exerts pronounced antifertilising effects, it is also a potent antiglucocorticoid (21) . But in contrast to other known antiglucocorticoids, like carboxamide derivatives of dexamethasone, RU 38486 forms stable complexes with the glucocorticoid receptor protein under low temperature conditions. These are destabilized only after heat activation, thus prohibiting an effective nuclear translocation (22) .
To what extent an RU 38486-"albumin"-complex, äs presented in this study, behaves like a receptor within the target cell is unknown; its ability to translocate into the nucleus and its possible nonspecific interaction with the receptor binding site on the level of chromatin, thus acting äs an antihormone, is entirely speculative but under investigation.
Finally, the high binding capacity of RU 38486 to albumin could lead to an enpraious intra-and extracellular accumulation of this steroid thus forming a pool of steroid, which cannot be metabolized but can be released slöwly. A long lasting hormonal iinpulse of a single dose of RU 38486, äs demonstrated in in-vivo experiments in rats, keeps the animal infertile for a long time.
